All In Biotech

Free tool

FAERS Monitor: Maxalt

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020864 or its brand name (Maxalt, Rizatriptan Benzoate). Reports on generic versions are filed under their own applications.

Reports

9,569

Serious

5,593

58% of reports

Hospitalization

1,955

Death reported

175

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,547
  • nausea1,200
  • headache1,016
  • off label use953
  • migraine934
  • product use in unapproved indication642
  • fatigue609
  • hyperhidrosis591
  • pain568
  • sedation498
  • nightmare497
  • nephrolithiasis457
  • vomiting447
  • diarrhoea419
  • dizziness404

Reports by year received

View as table
YearReports
200497
2005101
2006110
2007119
2008136
2009169
2010224
2011301
2012406
2013349
2014371
2015537
2016835
2017487
2018608
2019767
2020682
2021594
2022601
2023512
2024545
2025526
2026492

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,590 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sedationSignal49842.639.119,823
nightmareSignal49732.029.414,714
nephrolithiasisSignal45722.120.29,118
migraineSignal93421.720.418,333
hyperhidrosisSignal59110.19.44,860
product use in unapproved indicationSignal6425.75.32,510
headacheSignal1,0163.63.41,928
nauseaSignal1,2003.33.22,034
drug ineffectiveSignal1,5472.62.51,596
off label useSignal9532.42.3805
vomitingSignal4472.11.9259
painSignal5682.01.9306
dizziness4041.81.6141
fatigue6091.71.6190
diarrhoea4191.41.355

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.